Bayforest Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-306	Closed	-$82.6K	–	720
2025 Q1	$82.6K	Buy	306 +39	+15%	+$10.5K	0.04%	507
2024 Q4	$62.8K	Buy	+267	New	+$62.8K	0.08%	425